Cargando…
Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats
BACKGROUND: Triptolide treatment leads to an improvement in Diabetic Cardiomyopathy (DCM) in streptozotocin-induced diabetic rat model. DCM is characterized by abnormal cardiac energy metabolism. We hypothesized that triptolide ameliorated cardiac metabolic abnormalities in DCM. We proposed (31)P nu...
Autores principales: | Liang, Zhongshu, Leo, Sunnar, Wen, Helin, Ouyang, Mao, Jiang, Weihong, Yang, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431461/ https://www.ncbi.nlm.nih.gov/pubmed/25967112 http://dx.doi.org/10.1186/s12872-015-0030-4 |
Ejemplares similares
-
Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy
por: Wen, He-Ling, et al.
Publicado: (2013) -
Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats
por: Atta, Mustafa S., et al.
Publicado: (2018) -
Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Liu, Wenjuan, et al.
Publicado: (2018) -
Myocardial performance in conscious streptozotocin diabetic rats
por: Borges, Giulianna R, et al.
Publicado: (2006) -
Syringic Acid Attenuates Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Sabahi, Zahra, et al.
Publicado: (2021)